Glass House BrandsGLASF -0.80%44 PB Ratio is 12.60 as of Jun. 26, 2026, which is 327% above its 10-year median of 2.95. GuruFocus rates GLASF with a GF Score™ of 44/100 and a GF Value™ of $6.15 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 922 Drug Manufacturers companies, Glass House Brands ranks worse than 94.25% on this metric.
Glass House Brands Inc stock PB Ratio (=12.65) is close to 5-year high of 13.75.
The historical rank and industry rank for Glass House Brands's PB Ratio or its related term are showing as below:
GLASF'
s PB Ratio Range Over the Past 10 Years
Min: 0.44 Med: 2.95 Max: 13.75
Current: 12.64
During the past 6 years, Glass House Brands's highest PB Ratio was 13.75. The lowest was 0.44. And the median was 2.95.
GLASF's PB Ratio is ranked worse than 94.25% of 922
companies
in the Drug Manufacturers industry
Industry Median: 1.825
vs GLASF: 12.64
During the past 12 months, Glass House Brands's average Book Value Per Share Growth Rate was -39.70% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -28.50% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -12.00% per year.
During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Glass House Brands was 0.80% per year. The lowest was -28.50% per year. And the median was -22.00% per year.
Back to Basics: PB Ratio
Glass House Brands (OTCPK:GLASF) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Glass House Brands PB Ratio Related Terms
Glass House Brands PB Ratio Historical Data
* Premium members only.
The historical data trend for Glass House Brands's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Glass House Brands's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Glass House Brands PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Glass House Brands's PB Ratio distribution charts can be found below:
* The bar in red indicates where Glass House Brands's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Glass House Brands (GLASF) has a PB Ratio of 12.60 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Glass House Brands and its competitors. This is 327% above median its historical median of 2.95. Over the past decade, Glass House Brands' PB Ratio has ranged from 0.44 to 13.75. According to the industry distribution chart, Glass House Brands ranks #869 out of 922 companies in the Drug Manufacturers industry, placing it in the top 94.3%.
Is Glass House Brands' PB Ratio too high?
Glass House Brands' current PB Ratio of 12.60 is 327% above median its 10-year median of 2.95. Over the past 10 years, this metric has ranged from a low of 0.44 to a high of 13.75. The Drug Manufacturers industry median PB Ratio is 1.83. Glass House Brands' value of 12.60 is 590.4% above this industry median. Based on the distribution chart, Glass House Brands ranks #869 out of 922 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Glass House Brands has a GF Score™ of 44/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Glass House Brands' PB Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Glass House Brands ranks #869 out of 922 companies for PB Ratio. This places Glass House Brands in the lower half of its industry. The industry median PB Ratio is 1.83. Glass House Brands' value of 12.60 is 590.4% above this benchmark. Historically, Glass House Brands' own PB Ratio has ranged from 0.44 to 13.75 over the past decade. While the company's 10-year median is 2.95 vs. the industry median of 1.83, Glass House Brands has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.83, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Glass House Brands's current PB Ratio of 12.60 is 590.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Glass House Brands and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Glass House Brands's current PB Ratio is 12.60, which is 327% above median its own 10-year median of 2.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Glass House Brands stock overvalued right now?
Based on GuruFocus' analysis, Glass House Brands (GLASF) is currently considered Significantly Overvalued. The stock's GF Value™ is $6.15, compared to a current price of $12.64 — trading 105.5% above its estimated fair value. The current PB Ratio is 12.60, which is 327% above median its 10-year median of 2.95 and 590.4% above the Drug Manufacturers industry median of 1.83. Glass House Brands' overall GF Score™ is 44/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Glass House Brands (GLASF), the current PB Ratio is 12.60 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Glass House Brands (GLASF) Overvalued in 2026?
Based on GuruFocus' analysis, Glass House Brands stock appears to be overvalued.
The current stock price of $12.64 is trading 105.5% above its estimated GF Value™ of $6.15.
GuruFocus considers Glass House Brands to be Significantly Overvalued.
Key valuation signals for GLASF:
PB Ratio: 12.60 (327% above median its 10-year median of 2.95)
GF Value™: $6.15 vs. price of $12.64 (105.5% above fair value)
Industry Position: 590.4% above the Drug Manufacturers median (#869 of 922)
No single metric tells the full story. See the GLASF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Glass House Brands Inc is an integrated cannabis company that operates exclusively in the state of California. Its portfolio of brands includes Glass House Farms, Forbidden Flowers, and Mama Sue Wellness. It cultivates, manufactures, and distributes cannabis bulk flower and trim to wholesalers and consumer packaged goods to third-party retail stores. It also owns and operates retail cannabis stores in the state of California. It has three reportable segments: Retail, Wholesale Biomass, and Cannabis-related consumer packaged goods. It generates the majority of its revenue from the Wholesale Biomass segment.
44GF Score
Get the complete analysis for GLASF
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GLASF has been successfully added to your 
